Clinical Chemistry AACC Online Job Center
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 44: 250-255, 1998;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit an electronic Letter to
the Editor about this paper
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (36)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rodríguez-García, J.
Right arrow Articles by Rodríguez-Segade, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rodríguez-García, J.
Right arrow Articles by Rodríguez-Segade, S.
Related Collections
Right arrow Endocrinology and Metabolism
(Clinical Chemistry. 1998;44:250-255.)
© 1998 American Association for Clinical Chemistry, Inc.

Endocrinology and Metabolism

Increased concentrations of serum pentosidine in rheumatoid arthritis

Javier Rodríguez-García, Jesús R. Requenaa, and Santiago Rodríguez-Segade

Department of Biochemistry and Molecular Biology, Clinical Biochemistry Division, Hospital Xeral de Galicia, University of Santiago de Compostela, Santiago de Compostela, Spain.
a Author for correspondence at current address: Department of Chemistry and Biochemistry, University of South Carolina, Columbia, SC 29208. Fax 803-777-7272; e-mail requena{at}psc.sc.edu.

Advanced glycosylation end products (AGEs) are thought to play an important role in the development of diabetic complications. Oxidative reactions are essential for the formation of some AGEs, termed glycoxidation products. Increased concentrations of pentosidine, one of such products, are found in tissue and serum in diabetes mellitus and in end-stage renal disease, suggesting that hyperglycemia and impaired renal function are important factors in AGE accumulation. We hypothesized that increased concentrations of pentosidine would also be found in pathological conditions associated with increased oxidative stress. We measured pentosidine in sera of patients with rheumatoid arthritis (RA), systemic lupus erythematosus, and diabetes. Increased serum pentosidine was found in RA (108.4 ± 146.5 nmol/L, P <0.002) and in diabetes (69.6 ± 42.4 nmol/L, P <0.001) as compared with healthy subjects (48.3 ± 12.0 nmol/L). These results prove that AGEs may accumulate in the absence of hyperglycemia or impaired kidney function.




The following articles in journals at HighWire Press have cited this article:


Home page
 Hum ReprodHome page
H. Konishi, M. Nakatsuka, C. Chekir, S. Noguchi, Y. Kamada, A. Sasaki, and Y. Hiramatsu
Advanced glycation end products induce secretion of chemokines and apoptosis in human first trimester trophoblasts
Hum. Reprod., September 1, 2004; 19(9): 2156 - 2162.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Pathol.Home page
C. Rocken, R. Kientsch-Engel, S. Mansfeld, B. Stix, K. Stubenrauch, B. Weigle, F. Buhling, M. Schwan, and W. Saeger
Advanced Glycation End Products and Receptor for Advanced Glycation End Products in AA Amyloidosis
Am. J. Pathol., April 1, 2003; 162(4): 1213 - 1220.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
G. Hein and S. Franke
Are advanced glycation end-product-modified proteins of pathogenetic importance in fibromyalgia?
Rheumatology, October 1, 2002; 41(10): 1163 - 1167.
[Abstract] [Full Text] [PDF]

Home page
 Rheumatology (Oxford)Home page
J. R. Chen, M. Takahashi, M. Suzuki, K. Kushida, S. Miyamoto, and T. Inoue
Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis
Rheumatology, December 1, 1999; 38(12): 1275 - 1278.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1998 by the American Association for Clinical Chemistry.